Wellington Management Group
ONC

Wellington Management Group’s BeOne Medicines Ltd ONC Stock Holding History

Wellington Management Group’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.48M Buy
22,738
+1,910
+9% +$563K ﹤0.01% 1403
2026
Q1 		$6.19M Buy
20,828
+2,920
+16% +$945K ﹤0.01% 1365
2025
Q4 		$5.44M Buy
+17,908
New +$5.86M ﹤0.01% 1393
2023
Q4 		– Sell
-55,478
Closed -$9.98M – 1943
2023
Q3 		$9.98M Buy
55,478
+20,239
+57% +$4M ﹤0.01% 1108
2023
Q2 		$6.28M Buy
35,239
+25,947
+279% +$5.98M ﹤0.01% 1209
2023
Q1 		$2M Buy
+9,292
New +$2.23M ﹤0.01% 1514
2022
Q2 		– Sell
-75,004
Closed -$14.1M – 2221
2022
Q1 		$14.1M Sell
75,004
-675,876
-90% -$144M ﹤0.01% 1106
2021
Q4 		$203M Sell
750,880
-99,923
-12% -$33.7M 0.03% 443
2021
Q3 		$309M Sell
850,803
-91,113
-10% -$29.8M 0.05% 336
2021
Q2 		$323M Sell
941,916
-253,068
-21% -$83.8M 0.05% 323
2021
Q1 		$416M Sell
1,194,984
-248,554
-17% -$82.3M 0.07% 265
2020
Q4 		$373M Sell
1,443,538
-217,711
-13% -$59.9M 0.07% 268
2020
Q3 		$476M Sell
1,661,249
-295,862
-15% -$69.5M 0.1% 193
2020
Q2 		$369M Sell
1,957,111
-85,885
-4% -$14M 0.08% 214
2020
Q1 		$252M Sell
2,042,996
-244,801
-11% -$38.3M 0.07% 254
2019
Q4 		$379M Sell
2,287,797
-154,885
-6% -$25.7M 0.08% 248
2019
Q3 		$299M Sell
2,442,682
-24,542
-1% -$3.26M 0.07% 278
2019
Q2 		$306M Sell
2,467,224
-179,522
-7% -$22.8M 0.07% 273
2019
Q1 		$349M Sell
2,646,746
-123,567
-4% -$16.7M 0.08% 248
2018
Q4 		$389M Sell
2,770,313
-109,976
-4% -$14.6M 0.1% 217
2018
Q3 		$496M Buy
2,880,289
+412,423
+17% +$69.4M 0.1% 208
2018
Q2 		$379M Sell
2,467,866
-1,032,513
-29% -$184M 0.08% 248
2018
Q1 		$588M Sell
3,500,379
-313,227
-8% -$42.4M 0.13% 180
2017
Q4 		$373M Buy
3,813,606
+1,034,823
+37% +$94.7M 0.08% 245
2017
Q3 		$287M Buy
2,778,783
+1,296,030
+87% +$96.6M 0.07% 281
2017
Q2 		$66.7M Buy
1,482,753
+225,928
+18% +$8.9M 0.02% 643
2017
Q1 		$46M Buy
1,256,825
+171,704
+16% +$6.26M 0.01% 754
2016
Q4 		$32.9M Buy
+1,085,121
New +$34.1M 0.01% 843

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wellington Management Group's ONC Position: Q2 2026 in Review

Wellington Management Group increased its BeOne Medicines Ltd (ONC) stake by 9.2% in Q2 2026, buying an estimated $563K and bringing the position to 22,738 shares worth $6.48M. The position accounts for ﹤0.01% of the portfolio, ranked #1403.

Wellington Management Group first reported a position in ONC in Q4 2016 and has held it in 28 quarters since. The position peaked at $588M in Q1 2018. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Wellington Management Group held 22,738 shares of BeOne Medicines Ltd worth $6.48M as of Q2 2026.
  • Wellington Management Group bought 1,910 BeOne Medicines Ltd shares in Q2 2026, an estimated $563K.
  • BeOne Medicines Ltd made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1403 holding.
  • Wellington Management Group first reported a position in BeOne Medicines Ltd in Q4 2016 and has held it in 28 quarters since.
  • Wellington Management Group's BeOne Medicines Ltd position peaked at $588M in Q1 2018.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.